[HTML][HTML] Albumin replacement in patients with severe sepsis or septic shock

P Caironi, G Tognoni, S Masson… - … England Journal of …, 2014 - Mass Medical Soc
Background Although previous studies have suggested the potential advantages of albumin
administration in patients with severe sepsis, its efficacy has not been fully established. …

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

IS Anand, LD Fisher, YT Chiang, R Latini, S Masson… - Circulation, 2003 - Am Heart Assoc
Background— Neurohormones are considered markers of heart failure progression. We
examined whether changes in brain natriuretic peptide (BNP) and norepinephrine (NE) over …

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure

R Latini, S Masson, IS Anand, E Missov, M Carlson… - Circulation, 2007 - Am Heart Assoc
Background— Circulating cardiac troponin T, a marker of cardiomyocyte injury, predicts
adverse outcome in patients with heart failure (HF) but is detectable in only a small fraction of …

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

…, SN Singh, S Barlera, R Glazer, S Masson… - American heart …, 2005 - Elsevier
BACKGROUND: Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative
prognostic factor. Recent studies indicate that the incidence of AF might be decreased by …

C-reactive protein in heart failure: prognostic value and the effect of valsartan

…, VG Florea, MA Kuskowski, T Rector, S Masson… - Circulation, 2005 - Am Heart Assoc
Background— The role of C-reactive protein (CRP) in heart failure is not well studied. We
assessed the prognostic value of CRP in patients randomized in Val-HeFT (Valsartan Heart …

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the …

S Masson, R Latini, IS Anand, T Vago… - Clinical …, 2006 - academic.oup.com
Background: The B-type or brain natriuretic peptides (BNP) and the amino-terminal probrain
natriuretic peptide (NT-proBNP) are good markers of prognosis and diagnosis in chronic …

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

S Masson, R Latini, IS Anand, S Barlera… - Journal of the American …, 2008 - jacc.org
Objectives : This study sought to evaluate the association between changes over time of N-terminal
pro-brain natriuretic peptide (NT-proBNP) expressed in different ways and outcome …

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT

R Latini, S Masson, I Anand, M Salio… - European heart …, 2004 - academic.oup.com
Aims Plasma levels of individual neurohormones (NH) have been proposed as reliable
indicators for risk stratification of patients with heart failure (HF). Mainly because of small sample …

Lung stress and strain during mechanical ventilation: any safe threshold?

…, G Conte, S Gatti, O Leopardi, S Masson… - American journal of …, 2011 - atsjournals.org
Rationale: Unphysiologic strain (the ratio between tidal volume and functional residual
capacity) and stress (the transpulmonary pressure) can cause ventilator-induced lung damage. …

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)

R Latini, S Masson, I Anand, D Judd, AP Maggioni… - Circulation, 2002 - Am Heart Assoc
Background— Brain natriuretic peptide (BNP) and norepinephrine (NE) are strongly related
to severity of and are independent predictors of outcome in heart failure. The long-term …